Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib and cryotherapy in advanced NSCLC
NCT02744664Phase 4Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Apr 2016
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of icotinib in non-small cell lung cancer (NSCLC), sponsored by Fuda Cancer Hospital. Started Apr 2016; status: completed.
02
Drugs
icotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02744664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744664.